M with antiphospholipid syndrome c/b portal vein thrombosis and superior mesenteric vein thrombosis with prior partial hepatic vein inclusion on Lovenox, grade III esophageal varices, portal gastropathy, who presents with 4 episodes of BRBPR that started the day prior to admission around 5 pm.
Last dose of Lovenox this AM.
The patient vagaled while an IV was being placed with bradcardia to 30s and hypotension with SBP in upper 80s.
The patient was started on octreotide gtt.
Past Medical History: - Antiphospholipid antibody syndrome - JAK2 mutation indicative of myeloproliferative syndrome - CBD stones and cholangitis s/p ERCP in [**5-25**] - Portal vein thrombosis in [**2108**], thought to be secondary to antiphospholipid antibody syndrome, recently switched to Lovenox after recurrent thrombosis while on therapeutic coumadin therapy - Status post cholecystectomy [**2113**] - Grade 3 esophageal varices seen on ERCP [**5-25**] - Portal gastropathy in the stomach - Periampullary varix - Hemorrhoids  Social History: School administrator and headmaster, is married with 2 children.
Denies smoking, has occasional alcohol, one glass of wine at night.
Endotracheal tube and right central catheter remain in place.
[**2119-8-4**] CXR: In comparison with study of [**8-4**], there has been placement of a right IJ catheter that extends to the lower portion of the SVC.
Cyanoacrylate injection was applied at two points along the variceal cord, for hemostasis and sclerotherapy with success.
M with antiphospholipid syndrome c/b portal vein thrombosis and superior mesenteric vein thrombosis with prior partial hepatic vein inclusion on Lovenox, grade III esophageal varices, portal gastropathy, who presents with BRBPR.
In the setting of intubation he likely aspirated and was started on antibiotics for aspiration (on ceftriaxone for infection PPX anyways) this will be continued for 8 day course.
He then underwent a flex sig which revealed old blood.
He was eventually reprepped and found to have a rectal varix which was banded and 3 polyps which will require repeat outpatient C scope.
Bleeding had stopped, hemodynamically stable, on octreotide drip x 5 days.
heparin sc for dvt ppx restarted on [**8-9**] and lovenox treatment dose restarted on [**8-9**] s/p central line plcmt which was discontinued on [**8-9**].
aspiration in setting of endoscopy which was < 24 hours from admission so treated w/ ceftriaxone alone.
Lovenox initially held given bleeding.
On the floor Nadolol was restarted and IV PPI was continued.
On discharge plans were made for follow up for repeat banding and patient was placed on an oral ppi.
Aspiration PNA: Initially patient reguired 2L nasal canula.
Antibiotics were continued and incentive spirometry was encouraged.
Medications on Admission: Lovenox 160 mg SQ daily Nadolol 20 mg po daily Ursodiol 300 mg po TID  Discharge Medications: 1.
Ursodiol 300 mg Capsule Sig: One (1) Capsule PO TID (3 times a day).
Nadolol 20 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Omeprazole 40 mg Capsule, Delayed Release(E.C.)
Enoxaparin 120 mg/0.8 mL Syringe Sig: One (1)  Subcutaneous once a day.
Because, of this bleeding you required a blood transfusion.
Please make sure to continue your medications as prescribed.
The following changes were made to your regimen: - Start taking omeprazole 40 mg daily.
If you experience any increasing abdominal pain, nausea/vomiting, diarrhea, dark/tarry stools or bloody stools, fevers, chills, or any other concerning symptoms please call your doctor or return to the emergency room.
